> What’s up with that? I suspect it's all about who benefits. In the food industry, we've seen the effects, the industry is consolidating and forcing smaller

> What’s up with that? I suspect it's all about who benefits. In the food industry, we've seen the effects, the industry is consolidating and forcing smaller players out. In the case of generic prescription drugs, those are still very large players. There seems to be a cartel for all but the most common drugs, where manufacturers don't bother competing for market share.